Floatz logo

32 assets in Long COVID-19

Therapeutic assets addressing Long COVID-19, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Immulina Tm
Long COVID-19
University of Mississippi Medical CenterP3BB (64)
Ivabradine
Long COVID-19
Kanecia Obie ZimmermanP2B (62)
Melatonin
Long COVID-19
Duke UniversityP2B (62)
NORVIR
Long COVID-19
Kanecia Obie ZimmermanP2B (62)
Paxlovid
Long COVID-19
Kanecia Obie ZimmermanP2B (62)
Sirolimus
Long COVID-19
Icahn School of Medicine at Mount SinaiP3B (62)
Solriamfetol
Long COVID-19
Duke UniversityP2B (62)
Baricitinib
Long COVID-19
Vanderbilt University Medical CenterP3B (60)
Colchicinum
Long COVID-19
Janneke van de WijgertP3B (60)
Metformin
Long COVID-19
Janneke van de WijgertP3B (60)
Modafinil
Long COVID-19
Duke UniversityP2B (60)
Amantadine
Long COVID-19
Ohio State UniversityP2B (57)
axa1125
Long COVID-19
Axcella Health, IncP2B (57)
BC 007
Long COVID-19
Berlin Cures GmbHP2B (57)
Beclomethasone
Long COVID-19
Duke UniversityP2B (57)
Human Immunoglobulins
Long COVID-19
Kanecia Obie ZimmermanP2B (57)
Nirmatrelvir
Long COVID-19
Stanford UniversityP2B (57)
Temelimab
Long COVID-19
GeNeuro SAP2B (57)
Tnx-102 Sl
Long COVID-19
Tonix Pharmaceuticals, Inc.P2B (57)
Vortioxetine
Long COVID-19
Brain and Cognition Discovery FoundationP2B (57)
ci-581a
Long COVID-19
New York State Psychiatric InstituteP2CCC (53)
ci-581b
Long COVID-19
New York State Psychiatric InstituteP2CCC (53)
Ipilimumab
Long COVID-19
Universita di VeronaP2CCC (53)
Naltrexone
Long COVID-19
Brigham and Women's HospitalP2CCC (53)
Nivolumab
Long COVID-19
Universita di VeronaP2CCC (53)
Paragon Novel Metabolic Regulator
Long COVID-19
ParagonClinicals Inc.P2CCC (53)
Pyridostigmine
Long COVID-19
Brigham and Women's HospitalP2CCC (53)
Marcaine
Long COVID-19
Jonathann Kuo, MDP1CC (47)
Atcell
Long COVID-19
American CryoStem CorporationP1CC (43)
Pembrolizumab
Long COVID-19
National Institute of Neurological Disorders and Stroke (NINDS)P1CC (43)
PS13
Long COVID-19
National Institute of Mental Health (NIMH)P1CC (43)
Liraglutide
Long COVID-19
University of ChicagoEarly P1C (39)